IL-33 attenuates cardiac remodeling following myocardial infarction via inhibition of the p38 MAPK and NF-κB pathways.

Yin, Honglei

IL-33 attenuates cardiac remodeling following myocardial infarction via inhibition of the p38 MAPK and NF-κB pathways. [electronic resource] - Molecular medicine reports May 2014 - 1834-8 p. digital

Publication Type: Journal Article; Retracted Publication

1791-3004

10.3892/mmr.2014.2051 doi


Animals
Apoptosis--drug effects
Disease Models, Animal
Echocardiography
Inflammation--metabolism
Interleukin-33
Interleukins--pharmacology
Mice
Myocardial Infarction--metabolism
Myocardium--metabolism
NF-kappa B--metabolism
Phosphorylation--drug effects
Signal Transduction--drug effects
Ventricular Function, Left
Ventricular Remodeling--drug effects
p38 Mitogen-Activated Protein Kinases--metabolism